What long-term trends can investors see in CLOV's EPS from 2024?
4/12/2025 05:39pm
Clover Health (CLOV) experienced a negative EPS of $0.08 for the 2024 Q4 period, which reflects a challenging financial performance for the company. This negative trend suggests that investors should be cautious and monitor the company's financial performance closely, as it indicates a potential lack of profitability or cash generation capacity for the period.
|code|Ticker|Name|Date|Diluted EPS YoY|Diluted EPS|market_code|
|---|---|---|---|---|---|---|
|CLOV|CLOV.O|Clover Health|2024 Q1|75|-0.04|185|
|CLOV|CLOV.O|Clover Health|2024 Q2|116.66666666666666|0.01|185|
|CLOV|CLOV.O|Clover Health|2024 Q3|77.77777777777777|-0.02|185|